PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Antisense Therapeutics appoints new Non-Executive Director, page-24

  1. 266 Posts.
    lightbulb Created with Sketch. 8


    ANP is a fly speck compared to CSL which tells me that she sees something very special here. I just can't believe how huge a deal this is to have such a heavy hitter on our team to negotiate with the EMA and FDA. This is like acquiring a Hall of Fame pitcher in the prime of their career. Just such an incredibly huge step to have her on board.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.